T0	MultiCitation 571 572	5
T1	Context 472 574	Recently, a subgroup of Basal-like tumors associated with poor prognosis has also been reported [4,5].
T2	CONTRADICT 1651 2091	Clinically, the majority of claudin-low tumors are poor prognosis estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and epidermal growth factor receptor 2 (HER2)-negative (triple negative) invasive ductal carcinomas with a high frequency of metaplastic and medullary differentiation. They also have a response rate to standard preoperative chemotherapy that is intermediate between that of basal-like and luminal tumors.
